Literature DB >> 25622189

Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo.

Lucas A Lane1, Ximei Qian, Andrew M Smith, Shuming Nie.   

Abstract

Nanomedicine is an interdisciplinary field of research at the interface of science, engineering, and medicine, with broad clinical applications ranging from molecular imaging to medical diagnostics, targeted therapy, and image-guided surgery. Despite major advances during the past 20 years, there are still major fundamental and technical barriers that need to be understood and overcome. In particular, the complex behaviors of nanoparticles under physiological conditions are poorly understood, and detailed kinetic and thermodynamic principles are still not available to guide the rational design and development of nanoparticle agents. Here we discuss the interactions of nanoparticles with proteins, cells, tissues, and organs from a quantitative physical chemistry point of view. We also discuss insights and strategies on how to minimize nonspecific protein binding, how to design multistage and activatable nanostructures for improved drug delivery, and how to use the enhanced permeability and retention effect to deliver imaging agents for image-guided cancer surgery.

Entities:  

Keywords:  active targeting; antifouling; fluorescent dyes; image-guided surgery; molecular imaging; oncology; passive targeting

Mesh:

Substances:

Year:  2015        PMID: 25622189     DOI: 10.1146/annurev-physchem-040513-103718

Source DB:  PubMed          Journal:  Annu Rev Phys Chem        ISSN: 0066-426X            Impact factor:   12.703


  39 in total

Review 1.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

2.  Influences of nanocarrier morphology on therapeutic immunomodulation.

Authors:  Molly Frey; Sharan Bobbala; Nicholas Karabin; Evan Scott
Journal:  Nanomedicine (Lond)       Date:  2018-08-07       Impact factor: 5.307

3.  Quantum Dot Surface Engineering: Toward Inert Fluorophores with Compact Size and Bright, Stable Emission.

Authors:  Sung Jun Lim; Liang Ma; André Schleife; Andrew M Smith
Journal:  Coord Chem Rev       Date:  2016-04-19       Impact factor: 22.315

4.  Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer.

Authors:  Zhimin Tao; Mandar Deepak Muzumdar; Alexandre Detappe; Xing Huang; Eric S Xu; Yingjie Yu; Tarek H Mouhieddine; Haiqin Song; Tyler Jacks; P Peter Ghoroghchian
Journal:  Nano Lett       Date:  2018-03-21       Impact factor: 11.189

Review 5.  Cooperativity Principles in Self-Assembled Nanomedicine.

Authors:  Yang Li; Yiguang Wang; Gang Huang; Jinming Gao
Journal:  Chem Rev       Date:  2018-04-25       Impact factor: 60.622

6.  Towards clinically translatable in vivo nanodiagnostics.

Authors:  Seung-Min Park; Amin Aalipour; Ophir Vermesh; Jung Ho Yu; Sanjiv S Gambhir
Journal:  Nat Rev Mater       Date:  2017-05-03       Impact factor: 66.308

Review 7.  Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.

Authors:  Mauro Sousa de Almeida; Eva Susnik; Barbara Drasler; Patricia Taladriz-Blanco; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Chem Soc Rev       Date:  2021-03-05       Impact factor: 54.564

Review 8.  Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later.

Authors:  Gudrun C Thurner; Paul Debbage
Journal:  Histochem Cell Biol       Date:  2018-11-16       Impact factor: 4.304

9.  Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy.

Authors:  Hong-Jun Li; Jin-Zhi Du; Xiao-Jiao Du; Cong-Fei Xu; Chun-Yang Sun; Hong-Xia Wang; Zhi-Ting Cao; Xian-Zhu Yang; Yan-Hua Zhu; Shuming Nie; Jun Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

Review 10.  Clinical experiences with systemically administered siRNA-based therapeutics in cancer.

Authors:  Jonathan E Zuckerman; Mark E Davis
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.